4//SEC Filing
PASCALE ADAM 4
Accession 0001613377-19-000002
CIK 0000946644other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 11:57 AM ET
Size
6.2 KB
Accession
0001613377-19-000002
Insider Transaction Report
Form 4
Pascale Adam
Chief Accounting Officer
Transactions
- Conversion
Common Stock
2019-05-08+35,000→ 147,148 total - Conversion
Common Stock
2019-03-18+50,000→ 112,148 total
Footnotes (2)
- [F1]Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the ten shares issued.
- [F2]Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares.
Documents
Issuer
HEMISPHERX BIOPHARMA INC
CIK 0000946644
Entity typeother
Related Parties
1- filerCIK 0001613377
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 11:57 AM ET
- Size
- 6.2 KB